| 1 |
Xing Y, Yu Q, Zhou L, Cai W, Zhang Y, Bi Y, Zhang Y, Fu Z, Han L. Cytochrome P450-mediated herb-drug interaction (HDI) of Polygonum multiflorum Thunb. based on pharmacokinetic studies and in vitro inhibition assays. Phytomedicine 2023;112:154710. [PMID: 36805481 DOI: 10.1016/j.phymed.2023.154710] [Reference Citation Analysis]
|
| 2 |
Tom Hosack, Djamil Damry, Sujata Biswas. Drug-induced liver injury: a comprehensive review. Therap Adv Gastroenterol 2023;16:17562848231163410. [ DOI: 10.1177/17562848231163410] [Reference Citation Analysis]
|
| 3 |
Méndez-sánchez N, Teschke R. Drug-induced liver injury caused by conventional drugs, using cases based on the Roussel Uclaf causality assessment method. Comprehensive Guide to Hepatitis Advances 2023. [DOI: 10.1016/b978-0-323-98368-6.00002-1] [Reference Citation Analysis]
|
| 4 |
Teschke R. Treatment of Drug-Induced Liver Injury. Biomedicines 2022;11. [PMID: 36672522 DOI: 10.3390/biomedicines11010015] [Reference Citation Analysis]
|
| 5 |
Roth RA, Kana O, Filipovic D, Ganey PE. Pharmacokinetic and toxicodynamic concepts in idiosyncratic, drug-induced liver injury. Expert Opin Drug Metab Toxicol 2022;:1-13. [PMID: 36003040 DOI: 10.1080/17425255.2022.2113379] [Reference Citation Analysis]
|
| 6 |
Honarvari B, Karimifard S, Akhtari N, Mehrarya M, Moghaddam ZS, Ansari MJ, Jalil AT, Matencio A, Trotta F, Yeganeh FE, Farasati Far B, Arki MK, Naimi-jamal MR, Noorbazargan H, Lalami ZA, Chiani M. Folate-Targeted Curcumin-Loaded Niosomes for Site-Specific Delivery in Breast Cancer Treatment: In Silico and In Vitro Study. Molecules 2022;27:4634. [DOI: 10.3390/molecules27144634] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 7 |
Raschi E, Caraceni P. Letter to the editor: RECAM for the diagnosis of DILI-Is it time to incorporate additional pharmacological criteria? Hepatology 2022;76:E25-6. [PMID: 35220617 DOI: 10.1002/hep.32407] [Reference Citation Analysis]
|
| 8 |
Raschi E, Fusaroli M, Gatti M, Caraceni P, Poluzzi E, De Ponti F. Liver Injury with Nintedanib: A Pharmacovigilance-Pharmacokinetic Appraisal. Pharmaceuticals (Basel) 2022;15:645. [PMID: 35631471 DOI: 10.3390/ph15050645] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 9 |
Dong H, You J, Zhao Y, Zheng D, Zhong Y, Li G, Weng Z, Luo H, Jiang S. Study on the Characteristics of Small-Molecule Kinase Inhibitors-Related Drug-Induced Liver Injury. Front Pharmacol 2022;13:838397. [DOI: 10.3389/fphar.2022.838397] [Reference Citation Analysis]
|
| 10 |
Ye L, Feng Z, Huang L, Guo C, Wu X, He L, Tan W, Wang Y, Wu X, Hu B, Li T, Yang G, Chengxian G, He Q. Causality Evaluation of Drug-Induced Liver Injury in Newborns and Children in the Intensive Care Unit Using the Updated Roussel Uclaf Causality Assessment Method. Front Pharmacol 2021;12. [DOI: 10.3389/fphar.2021.790108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 11 |
Teschke R, Vongdala N, Quan NV, Quy TN, Xuan TD. Metabolic Toxification of 1,2-Unsaturated Pyrrolizidine Alkaloids Causes Human Hepatic Sinusoidal Obstruction Syndrome: The Update. Int J Mol Sci 2021;22:10419. [PMID: 34638760 DOI: 10.3390/ijms221910419] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 12 |
Teschke R, Danan G. The LiverTox Paradox-Gaps between Promised Data and Reality Check. Diagnostics (Basel) 2021;11:1754. [PMID: 34679453 DOI: 10.3390/diagnostics11101754] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 13 |
Clinton JW, Kiparizoska S, Aggarwal S, Woo S, Davis W, Lewis JH. Drug-Induced Liver Injury: Highlights and Controversies in the Recent Literature. Drug Saf 2021;44:1125-49. [PMID: 34533782 DOI: 10.1007/s40264-021-01109-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
